Advancing role of radiolabeled antibodies in the therapy of cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s00262-002-0348-5.pdf
Reference139 articles.
1. Akabani G, Cokgor I, Coleman RE, Gonzalez Trotter D, Wong TZ, Friedman HS, Friedman AH, Garcia-Turner A, Herndon JE, DeLong D, McLendon RE, Zhae XG, Pegram CN, Provenzale JM, Bigner DD, Zalutsky MR (2000) Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy. Int J Radiat Oncol Biol Phys 46:947–958
2. Amdur R, Bedfore J (1994) Dose-rate effects between 0.3 and 30 Gy/h in a normal and a malignant human cell line. Int J Radiat Oncol Biol Phys 30:83–90
3. Aurlien E, Larsen RH, Kvalheim G, Bruland OS (2000) Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate211At-rituximab against non-Hodgkin lymphoma cells. Br J Cancer 83:1375–1379
4. Axworthy DB, Reno JM, Hylarides MD, Mallett RW, Theodore LJ, Gustavson LM, Su F, Hobson LJ, Beaumier PL, Fritzberg AR (2000) Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc Natl Acad Sci U S A 97:1802–1807
5. Barbet J, Kraeber-Bodere F, Vuillez JP, Gautherot E, Rouvier E, Chatal JF (1999) Pretargeting with the affinity enhancement system for radioimmunotherapy. Cancer Biother Radiopharm 14:153–166
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Entry of nanoparticles into cells and tissues: status and challenges;Beilstein Journal of Nanotechnology;2024-08-12
2. Looking for New [1,2,4,5]Tetrazines to Produce 99mTc‐Labelled Derivatives, with a Suitable Lipophilicity Balance for Use in Bioorthogonal Reactions;ChemistrySelect;2023-11-02
3. Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes;Biomedicines;2023-04-28
4. Biodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: Possibilities and challenges;Advanced Drug Delivery Reviews;2022-07
5. Preparation, quality control, and biodistribution assessment of [ 111 In]In‐DOTA‐PR81 in BALB/c mice bearing breast tumors;Journal of Labelled Compounds and Radiopharmaceuticals;2021-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3